The hemostatic system accelerates plaque vulnerability to thrombosis in experimental models, although clinical evidence supporting this effect remains weak.
Absolute Event Rate: 0% vs 0%
Experimental data suggest that the hemostatic system can accelerate plaque vulnerability to thrombosis in vivo. However, clinical support for these findings remains weak. This comprehensive summary reviews the evidence.
Borissoff et al. (Wed,) reported a other. The hemostatic system accelerates plaque vulnerability to thrombosis in experimental models, although clinical evidence supporting this effect remains weak.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: